ROIVANT SCIENCES LTD. Earnings Per Share (Basic)
ROIVANT SCIENCES LTD. (ROIV) reported Earnings Per Share (Basic) of -$0.26 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasic · last filed 2026-08-06
- ROIVANT SCIENCES LTD. earnings per share, basic for the quarter ending 2026-06-30 was -$0.26.
- ROIVANT SCIENCES LTD. earnings per share, basic for the quarter ending 2025-12-31 was -$0.38, a 265.22% decline year-over-year.
- ROIVANT SCIENCES LTD. earnings per share, basic for the quarter ending 2025-09-30 was -$0.17.
- ROIVANT SCIENCES LTD. earnings per share, basic for the quarter ending 2025-06-30 was -$0.33, a 353.85% decline year-over-year.
- ROIVANT SCIENCES LTD. earnings per share, basic for fiscal 2026 was -$0.43.
- ROIVANT SCIENCES LTD. earnings per share, basic for fiscal 2025 was -$0.24, a 104.32% decline from fiscal 2024.
- ROIVANT SCIENCES LTD. earnings per share, basic for fiscal 2024 was $5.55.
- ROIVANT SCIENCES LTD. earnings per share, basic for fiscal 2023 was -$1.42.
| Period end | Earnings Per Share, Basic 3 month | Earnings Per Share, Basic 6 month | Earnings Per Share, Basic 9 month | Earnings Per Share, Basic 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$0.26 10-Q · filed 2026-08-06 | |||
| 2026-03-31 | -$0.43 10-K · filed 2026-05-20 | |||
| 2025-12-31 | -$0.38 10-Q · filed 2026-02-06 | -$0.88 10-Q · filed 2026-02-06 | ||
| 2025-09-30 | -$0.17 10-Q · filed 2025-11-10 | -$0.49 10-Q · filed 2025-11-10 | ||
| 2025-06-30 | -$0.33 10-Q · filed 2026-08-06 | |||
| 2025-03-31 | -$0.24 10-K · filed 2026-05-20 | |||
| 2024-12-31 | $0.23 10-Q · filed 2026-02-06 | $0.05 10-Q · filed 2026-02-06 | ||
| 2024-09-30 | -$0.31 10-Q · filed 2025-11-10 | -$0.18 10-Q · filed 2025-11-10 | ||
| 2024-06-30 | $0.13 10-Q · filed 2025-08-11 | |||
| 2024-03-31 | $5.55 10-K · filed 2026-05-20 | |||
| 2023-12-31 | $6.37 10-Q · filed 2025-02-10 | $5.79 10-Q · filed 2025-02-10 | ||
| 2023-09-30 | -$0.40 10-Q · filed 2024-11-12 | -$0.78 10-Q · filed 2024-11-12 | ||
| 2023-06-30 | -$0.38 10-Q · filed 2024-08-09 | |||
| 2023-03-31 | -$1.42 10-K · filed 2025-05-29 | |||
| 2022-12-31 | -$0.49 10-Q · filed 2024-02-13 | -$1.39 10-Q · filed 2024-02-13 | ||
| 2022-09-30 | -$0.42 10-Q · filed 2023-11-13 | -$0.89 10-Q · filed 2023-11-13 | ||
| 2022-06-30 | -$0.48 10-Q · filed 2023-08-14 | |||
| 2022-03-31 | -$1.26 10-K · filed 2023-06-28 | |||
| 2021-12-31 | -$0.41 10-Q · filed 2023-02-13 | -$0.87 10-Q · filed 2023-02-13 | ||
| 2021-09-30 | -$0.32 10-Q · filed 2022-11-14 | -$0.45 10-Q · filed 2022-11-14 | ||
| 2021-06-30 | -$0.13 10-Q · filed 2022-08-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |